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Three-dimensional chromosomal conformations
regulate transcription by moving enhancers and reg-
ulatory elements into spatial proximity with target
genes. Here we describe activity-regulated long-
range loopings bypassing up to 0.5 Mb of linear
genome to modulate NMDA glutamate receptor
GRIN2B expression in human and mouse prefrontal
cortex. Distal intronic and 30 intergenic loop forma-
tions competed with repressor elements to access
promoter-proximal sequences, and facilitated ex-
pression via a ‘‘cargo’’ of AP-1 and NRF-1 tran-
scription factors and TALE-based transcriptional
activators. Neuronal deletion or overexpression of
Kmt2a/Mll1 H3K4- and Kmt1e/Setdb1 H3K9-methyl-
transferase was associated with higher-order chro-
matin changes at distal regulatoryGrin2b sequences
and impairments in working memory. Genetic poly-
morphisms and isogenic deletions of loop-bound
sequences conferred liability for cognitive perfor-
mance and decreased GRIN2B expression. Dynamic
regulation of chromosomal conformations emerges
as a novel layer for transcriptional mechanisms im-
pacting neuronal signaling and cognition.INTRODUCTION
Gene expression is governed by distal regulatory elements,
including enhancers and locus control regions which have
been intensely studied in extraneural tissues such as blood for
more than 30 years (Banerji et al., 1981; Li et al., 1999). These
mechanisms, however, essentially remain unexplored in the
context of neuronal gene expression affecting cognition and
behavior. Based on genome-scale mappings of promoter-distal
regulatory regions for a large variety of cell lines and tissues,
including brain (Forrest et al., 2014; Andersson et al., 2014; Bern-
stein et al., 2012; Gerstein et al., 2012; Maher, 2012; Thurman
et al., 2012), it is estimated that each transcription start site
(TSS) is targeted on average by five different enhancers (Ander-
sson et al., 2014). Importantly, chromosomal loop formations are
critical for this layer of transcriptional regulation, because many
distal regulatory elements typically only become effective when
placed in close spatial proximity to the TSSs of their target
gene (Levine et al., 2014). Loop formations—which often require
CTCF-binding factor, cohesins, and various other proteins
assembled into scaffolds and anchors (Razin et al., 2013)—
potentially bypass many kilobases or even megabases (Mb) of
linear genome, thereby repositioning promoter-distal regulatory
elements next to their target promoters and TSSs (Gaszner
and Felsenfeld, 2006; Wood et al., 2010).
Here, we provide a deep and integrative analysis for the spatial
architectures of 800 kb noncoding sequence on humanNeuron 84, 997–1008, December 3, 2014 ª2014 Elsevier Inc. 997
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GRIN2B Higher-Order Chromatin and Cognition(mouse) chromosome 12p31.1 (6, 66.38cM), encompassing
N-methyl-D-aspartate (NMDA) glutamate receptor subunit
GRIN2B, which is broadly implicated in the neurobiology of
psychiatric disease, including schizophrenia and depression
(Ayalew et al., 2012; Fallin et al., 2005; Jiang et al., 2010; Mar-
tucci et al., 2006; O’Roak et al., 2012; Talkowski et al., 2012;
Weickert et al., 2013). We provide evidence for a complex and
multilayered regulatory network, involvingmultiple chromosomal
loopings that target the GRIN2B/Grin2b TSS and, depending on
their specific protein ‘‘cargo,’’ either repress or facilitate tran-
scription. Long-range promoter-enhancer interactions govern-
ing GRIN2B expression are conserved between human and
mouse brain, impact cognition and working memory, and
confer liability for psychiatric disease. The multidimensional
approaches presented here provide a roadmap to uncover
neurological function for the vast but largely unexplored noncod-
ing sequences in the human genome.
RESULTS
To explore spatial genome architectures at the NMDA receptor
GRIN2B locus, we employed chromosome conformation cap-
ture (3C) on prefrontal cortex (PFC) of adult subjects, and
cultured fibroblasts for comparison. Given that both theGRIN2B
gene body and the surrounding 50 and 30 sequences were epige-
netically decorated with sharp peaks for histone H3 acetylated at
lysine 27, an open chromatin mark broadly enriched at active
promoters and enhancers (Zhou et al., 2011), we screened
800 kb on chromosome 12 encompassingGRIN2B (Figure 1A).
Both PFC and FIB showed 3C PCR products for restriction frag-
ments positioned less than 50 kb from the TSS. However, PFC
but not FIB showed additional long-range interactions with in-
tronic and intergenic sequences 348 and 449 kb downstream
from the TSS (Figure 1B). These loops, which we hereafter
named GRIN2BTSS+348kb and GRIN2BTSS+449kb, were in the
PFC and neighboring cingulate cortex defined by sharp peaks
of histone H3 acetylated at lysine 27 (H3K27ac), an open chro-
matin mark enriched at active promoters and enhancers (Fig-
ure 1A and see Figures S1A and S1B online). Notably, GRIN2B
is expressed in PFC but not fibroblasts (Figure 1B). Therefore
the absence of GRIN2BTSS+348kb and GRIN2BTSS+449kb loopings
in fibroblasts would suggest a potential association with gene
expression. To further test this hypothesis, we monitored
GRIN2B RNA and the GRIN2BTSS+348kb and GRIN2BTSS+449kb
loopings during the course of neuronal differentiation, using
previously described protocols and induced pluripotent (iPS)
and H9 embryonic stem cell lines (Bharadwaj et al., 2013; Mitch-
ell et al., 2014). In both cell lines, neuronal differentiation was
associated with robust increases both in GRIN2B RNA and the
long-range loop, GRIN2BTSS+449kb (Figure 1C).
We noticed that the 50 end of GRIN2B is part of two long-
range chromosomal loop formations, GRIN2BTSS+348kb and
GRIN2BTSS+449kb (Figure 1B). Interestingly, convergence of
multiple loopings onto a common structure (‘‘chromatin hub’’)
had previously been associated with transcriptional regulation
and repression at theGlobin andMyb loci (de Laat andGrosveld,
2003; Harmston and Lenhard, 2013) and olfactory receptor
genes (Clowney et al., 2012). Therefore, we speculated that998 Neuron 84, 997–1008, December 3, 2014 ª2014 Elsevier Inc.GRIN2B expression could be governed by dynamic changes in
repressive and facilitative chromosomal loopings converging at
regulatory elements surrounding the GRIN2B TSS. To explore
this, we choose human embryonic kidney (HEK) 293 cells, which
robustly express several hundred neuronal genes, including
GRIN2B (Shaw et al., 2002). Interestingly, HEK293 chromatin
surrounding the GRIN2B gene showed multiple sharp peaks
for the CCCTC-binding factor and chromosomal loop-organizer
CTCF (Merkenschlager and Odom, 2013), with the strongest
binding around the distal arm of GRIN2BTSS+449kb (Figures 2A,
S1A, and S1B). CTCF and associated proteins function as
insulators and anchors for promoter-enhancer interactions and
often bind to sequences in direct proximity and overlap with
enhancer elements (Ghavi-Helm et al., 2014). Using 3C-ChIP-
loop (chromatin immunoprecipitation with conformation capture)
with an anti-CTCF antibody, we confirmed that the GRIN2B
TSS and its partnering sequences positioned +449 kb further
downstream are tethered together into higher-order chromatin
enriched with CTCF (Figure 2A). Furthermore, the distal arm of
GRIN2BTSS+449kb showed a strong enrichment for transcription
factors previously attributed a key regulatory role for GRIN2B
expression, including Nuclear Respiratory Factor 1 (NRF-1)
(Dhar and Wong-Riley, 2009; Priya et al., 2013) and Activating
Protein 1 (AP-1) (Qiang and Ticku, 2005) (Figures 2A, 2B, and
S1A). Using a minimal promoter/luciferase reporter assay,
we confirmed enhancer-like activity for two sequences in the
distal arm of GRIN2BTSS+449kb, each extending over 100–125
base pairs and defined by sharp, up to 40-fold, enrichment
for AP-1 motifs and NRF-1 and AP-1 proteins (Figure 2B).
From this, one would predict that weakening or disruption of
the GRIN2BTSS+449kb loop would result in decreased GRIN2B
expression. We generated stable HEK subclones with tet-on
transactivator controlled induction of the histone methyltransfer-
ase SET-domain Bifurcated 1 (SETDB1/ESET/KMT1E), a previ-
ously described negative regulator of GRIN2B expression which
confers, in human cell lines and mouse brain, repressive histone
H3-lysine K9 methylation at proximal intronic sequences
spreading up to 40 kb downstream from the TSS (Jiang et al.,
2010). Indeed, and as expected, doxycycline (DOX) but not
vehicle-treated SETDB1-inducible HEK cells showed a marked
upregulation of SETDB1 RNA and protein levels in conjunction
with decreased GRIN2B expression (Figure 2C). This was
associated with up to 5-fold increases in SETDB1 occupancy
at the GRIN2B TSS and gene-proximal intronic sequences,
in conjunction with localized histone H3K9 hypermethylation
and a strong 5- to 10-fold increase in occupancy of heterochro-
matin-associated protein 1 HP-1a (Figure 2D).
This ‘‘heterochromatization’’ around the TSS and first intron
showed only limited spreading across the wider GRIN2B locus,
because HP-1 and trimethyl-H3K9 remained at very low levels
at distal, loop-bound sequences, including GRIN2BTSS+449kb,
after DOX treatment. Conversely, proteins and histone marks
with a facilitatory role for gene expression and transcription,
including histone H3K27 acetylation and NRF-1 transcription
factor and AP-1 protein FOSL2, were maintained at high levels
at the sequences 449 kb dowstream from the TSS, regardless
of DOX treatment. This would suggest that SETDB1 induction
did not disrupt the molecular composition of the distal arm of
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Figure 1. Brain-Specific Higher-Order Chromatin at GRIN2B, Chr 12p31.1
(A) Linear map for 800 kb surrounding GRIN2B TSS, including GRIN2B gene body with exons and CpG islands as indicated. Browser tracks for (top to bottom)
H3K27ac in PFC and cingulate cortex (CG) (Zhu et al., 2013), H3K4me3 from PFC neurons (Cheung et al., 2010), and PFC-RNaseq (Bharadwaj et al., 2013).
(B) (Left) X-Y graphs (mean ± SD) present chromosome conformation capture (3C) profiles anchored on restriction fragment with TSS (green). (Top) Adult PFC
(n = 4) and (bottom) skin fibroblasts (n = 3). Notice much stronger interaction of red-marked fragments, peak 1 (distal arm of GRIN2BTSS+348kb loop) and peak 2
(distal arm of GRIN2BTSS+449kb), with the TSS specifically in brain, but not fibroblast (two-way ANOVA cell type 3 3C primer F [42,210] = 157.7, p < 0.001,
Newman-Keuls posthoc p < 0.001). (Right) Representative 3C PCR gels for four PFC specimens PFC 1–4 and cultured fibroblasts (FIB), showing 3C long-range
interactions of TSS with +348 kb (peaks 1) and +449 kb (peak 2) sequences specifically in PFC samples, and, as control, sequences within first intron. Bar graph
(mean ± SD; n = 3–4/group) comparing GRIN2B RNA in PFC and FIB.
(C) 3C PCR gels from iPS and iPS-derived differentiated neuronal culture (NEU-iPS), nl = 3C assays without ligase. Bar graphs (mean ± SD; n = 3–4/group)
quantify TSS-bound loopings with distal (+348 kb and +449 kb sequences) and proximal intron, as indicated. Significant changes after differentiation, GRIN2B
RNA:F(1,8) = 714.85, p < 0,001 and GRIN2B
TSS+449kb, F(1,8) = 507.35, p < 0,001; Newman-Keuls post hoc p < 0.001. See also Figure S1.
Neuron
GRIN2B Higher-Order Chromatin and Cognitionthe long-range loop, GRIN2BTSS+449kb (Figures 2D and 2F).
In sharp contrast, SETDB1 induction was associated with a
significant 30%–40% decrease in GRIN2BTSS+348kb and
GRIN2BTSS+449kb loopings, while the physical interactions be-
tween the TSS and the SETDB1 repressor-enriched proximal
intronic sequences were significantly increased (Figure 2E).
These experiments, taken together, demonstrate that SETDB1-
mediated downregulation of GRIN2B expression is associated
with dynamic repositioning of multiple distal DNA sequences
competing, via specific loop formations, for access to the
GRIN2B TSS and proximal promoters. Specifically, a localized
increase in repressive H3K9me3 and HP1 heterochromatin
around the TSS and the first intron is associated with disrup-
tion of long-range promoter-enhancer loopings, includingGRIN2BTSS+449kb. These mechanisms thereby effectively ‘‘shield’’
the TSS and gene-proximal promoters from the access to
GRIN2BTSS+449kb ‘‘cargo,’’ including AP-1 and NRF-1 transcrip-
tion factors (Figure 2F).
Having mapped GRIN2B higher-order chromatin in human
PFC and explored the dynamics and competitive interactions
of repressive and facilitative loopings in the HEK293 model, we
next askedwhether thesemechanisms represent conserved reg-
ulatory mechanisms across different mammalian lineages. 3C
assays on adult mouse cortex confirmed two long-range loop-
ings, Grin2bTSS+378kb and Grin2bTSS+471kb, which harbored se-
quences with up to 90% conservation to portions of the distal
arms of the human loops,GRIN2BTSS+348kb andGRIN2BTSS+449kb
(Figures S1C–S1F and S2A). Similarities in histone modificationNeuron 84, 997–1008, December 3, 2014 ª2014 Elsevier Inc. 999
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Figure 2. Coordinated Regulation of Multiple Chromosomal Loopings Targeting GRIN2B TSS
(A) Browser tracks from ENCODE data collection (Bernstein et al., 2012), showing highest enrichments for (top) CTCF and (bottom) NRF-1 proteins in
sequences +449 kb downstream from TSS (arrows). Bottom gels, PCR from 3C-ChIP-loop with anti-CTCF antibody (HEK293 cells), showing CTCF enrichment
specific for GRIN2BTSS+449kb loop.
(B) (Top) A total of 4 kb of GRIN2BTSS+449kb (chr 12, 13,680,308–13,684,308) showing (bars) elevated density of AP-1 motifs and increased AP-1 and NRF-1
occupancy in ENCODE ChIP-seq tracks (Bernstein et al., 2012). (Bottom) Reporter assay for three 100–125 bp sequences (C, control) and 2a, 2b from red box
number 2 (= GRIN2BTSS+449kb) shown in (A), showing up to 6-fold increase in minimal promoter-TATA box luciferase activity.
(C) (Top) Immunoblots (left) anti-SETDB1, (right) anti-FLAG antibody recognizing inducible FLAG-SETDB1 protein and (bottom) quantitative RT-PCR assays from
stable HEK293 clone for inducible SETDB1 expression. Note robust induction ofSETDB1, and parallel decline inGRIN2BRNA, 72 hr after addition of doxycycline
(+DOX), compared to untreated culture (DOX).
(D) ChIP-PCR, with (left) repressive SETDB1, HP1 and H3K9me3, and (right) facilitative H3K27ac, AP-1, and NRF-1 in chromatin across GRIN2B locus, as
indicated (gray box, 250 kb [upstream from TSS] control sequence; green box, TSS; red box number 1, GRIN2BTSS+348kb and number 2, GRIN2BTSS+449kb;
yellow box, intronic repressor and SETDB1 target site). Striped (white) bars, + () DOX.
(E) 3C PCR expressed as fold change (+DOX/DOX). Notice decrease in long-range loopings, GRIN2BTSS+348kb and GRIN2BTSS+449kb, in conjunction with (D)
localized, SETDB1-mediated H3K9 hypertrimethylation and HP1 binding at proximal intronic sequences <40 kb from TSS. All bar graphs are n = 3 group, mean ±
(B) SEM, (C–E) SD. *p < 0.05, **p < 0.01, ***p < 0.001, two-way ANOVA (ChIP) and unpaired t tests after Bonferroni correction (3C, qRT-PCR, luciferase assays).
(F) Dynamic model: long-range GRIN2BTSS+348kb and GRIN2BTSS+449kb loops are absent in cells not expressing GRIN2B. Upon GRIN2B expression, AP-1- and
NRF-1-enriched enhancer elements, positioned in the distal arm ofGRIN2BTSS+449kb, undergo relocation and aremoved into close spatial proximity with the TSS.
This is counterbalanced by shorter-range TSS-bound intronic loopings enriched with repressive chromatin. See also Figure S1.
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GRIN2B Higher-Order Chromatin and Cognitionprofiles between human and mouse cortex included a single
sharp peak for the transcriptional mark, trimethyl-histone H3K4
(H3K4me3), at the TSS and H3K27ac enrichment at loop-bound
sequences (Figures 1A, 3A, 3B, and S2B). Furthermore, intronic
sequences positioned up to 40 kb from the Grin2b TSS are sen-
sitive to SETDB1-mediated repressive chromatin remodeling in
mouse cortical neurons (Jiang et al., 2010), similar to SETDB1’s1000 Neuron 84, 997–1008, December 3, 2014 ª2014 Elsevier Inc.action in (human) HEK293 cells (Figures 2C and 2D). Therefore,
we predicted that increased SETDB1 occupancy at TSS-bound
intronic sequences in mouse cortex will result in significant
weakening of the long-range loops, Grin2bTSS+378kb and
Grin2bTSS+471kb. We conducted 3C on cortex of transgenic
mice expressing full-length Setdb1 under control of the neuron-
specific 9 kb calcium/calmodulin-dependent kinase II promoter
0.0
0.5
1.0
1.5
2.0
2.5
        0                                                                                    250                                                                             500  kb 
0 10 20 30 40
***
H3K4me3
H3K27Ac
 1  2
370 465 (kb)385 480
** **
**
**
**
   **
 *
   Setdb1
   Grin2b
     TSS
3C
 T
g 
/ W
t
 1  2
 1  2
Chr6:135,623,529Chr6:136,123,529
F
VP64 EGFP
TCAATAAACGTTAACTACAC
x
     TSS
 1
   Grin2b
 2
*
 1  2
*
 p=.0502
 **
DM
SO
0.0
0.5
1.0
DM
SOPT
X
PT
X
PT
X
DM
SO
0
   0      31      378    471
0
Se
td
b1
  C
hI
P
   1     2
(kb)
G
rin
2b
 R
N
A
3C
  1
  4
  5
2
3
   SET
2
4
6
     TSS
0
2
4
6
*
50-
250-
150-
kDa
 Grin2b
 α-Tubulin
G
rin
2b
 R
N
A
G
rin
2b
  p
ro
te
in
0.0
0.2
0.4
0.6
0.8
*
        Tg
Wt Tg
0.0
0.5
1.0
1.5
R
N
A
Gr
in2
b
Gr
in2
a
Se
tdb
1
*
Con TALE
     TSS
gTtWgTtW
NG
10
8
-1
0
1
2
3
4
TA
LE
-V
P
64
 C
hI
P
*
Grin2b
Gapdh
N2A NG108   Neu
Wt
   Setdb1
1
2
1 2
2
1
Ne
uro
ns
N2
A
A
B
C
D
E
Figure 3. Higher-Order Grin2b Chromatin in Mouse Cerebral Cortex and Hippocampal Neurons
(A) A total of 500 kb of linear genome (mm9, chromosome 6, 135,623,529–136,123,529), encompassing Grin2b, including TSS (green), proximal intronic
sequences targeted by SETDB1 (yellow), and two loop loopings (red) (1) Grin2bTSS+378kb and (2) Grin2bTSS+471kb, with sequences homolog to human
GRIN2BTSS+348kb and GRIN2BTSS+449kb (Figure S1).
(B) Browser tracks for histone marks H3K4me3 and H3K27ac in adult mouse cerebral cortex (Dixon et al., 2012).
(C) Fold-change (CK-Setdb1 transgenic (Tg)/wild-type littermate (Wt) of 3C PCR from adult Tg and Wt cortex (see also Figure S2). Notice increased physical
interactions of (yellow) TSS bound +15 to +40 kb intronic sequence, and significant decrease in (red box number 1) Grin2bTSS+378kb and (red box number 2)
Grin2bTSS+471kb. Two-way ANOVA, 3C interaction 3 genotype F (7,32) = 54.905 (p < 0.001). Newman-Keuls post hoc, *p < 0.05, **p < 0.01.
(D) Quantification ofGrin2b (left) RNA and (right) protein in adult (6- to 8-week)CK-Setdb1 Tg and wild-type (Wt) littermate control cortex. Mean ± SD, n = 5 (RNA)
and n = 3 (immunoblot)/group.
(E) Activity-dependent regulation of Grin2b higher-order chromatin in hippocampal neurons. (top, left to right) Grin2b RNA, 3C quantification of Grin2bTSS+378kb
and Grin2bTSS+471kb and SETDB1 occupancy across four regulatory sequences at Grin2b locus. Note significant increase at SETDB1 target site after 15 hr of
picrotoxin (PTX) or vehicle control (DMSO). n = 3–6 experiments/group, data shown as mean ± SD.
(F) (Left) Grin2b-TALE-VP64-GFP specifically targets mouse Grin2b loop 2 (Grin2bTSS+471kb), 471 kb downstream of TSS. Images show Neuro2A cells and
cultured hippocampal neurons expressing GFP-tagged TALE-VP64. RT-PCR for Grin2b and Gapdh control showing specific expression in cultured neurons.
(Right) Anti-TALE-VP64 ChIP in N2A and NG108 cells and primary cortical neurons, expressed (y axis) as fold change compared to nontransfected condition
(n = 3/group [mean ± SEM], *two-way ANOVA cell type3 TALE-VP64 binding F[2,12] = 4.04, p < 0.05, Bonferroni post hoc p < 0.05). RT-PCRGrin2b,Grin2a, and
Setdb1 RNA levels in neurons transfected with TALE-VP64-EGFP (TALE), compared to mock-transfected neurons (Con). Notice specific TALE-VP64-mediated
increase in Grin2b RNA (n = 6 per group, mean ± SEM, *p < 0.05, t test). See also Figures S1 and S2.
Neuron
GRIN2B Higher-Order Chromatin and Cognition(CK) in adult forebrain neurons (Jiang et al., 2010). Indeed, 3C
PCR from adult CK-Setdb1 cortex showed, in comparison
to littermate controls, significant decreases in Grin2bTSS+378kb
and Grin2bTSS+471kb, while interactions between the TSS andproximal intronic sequences surrounding the SETDB1 target
site were increased (Figures 3C and S2A). In addition, as previ-
ously reported (Jiang et al., 2010),Grin2b RNA and protein levels
were significantly decreased in CK-Setdb1 cortex (Figure 3D).Neuron 84, 997–1008, December 3, 2014 ª2014 Elsevier Inc. 1001
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GRIN2B Higher-Order Chromatin and CognitionHaving shown SETDB1-mediated regulation of GRIN2B/
Grin2b expression and long-range loopings in HEK cells (Figures
2C and 2D) and transgenic CK-Setdb1 cerebral cortex (Fig-
ure S2A), we then asked whether these mechanisms represent
a physiological mechanism that operates in wild-type neurons
to fine-tune Grin2b expression in a functional context, such as
dynamic changes in synaptic activity. To this end, primary
neuronal cultures from C57Bl6 hippocampi were exposed for
4–48 hr to GABAA receptor antagonist (picrotoxin/PTX, 100 mM)
to increase activity. In comparison to vehicle (DMSO), PTX-
treated cultures showed increased SETDB1 occupancy at TSS-
bound intronic sequences, which was associated with a decline
in Grin2b RNA most pronounced after 15 hr of treatment, result-
ing in decreased expression of protein. These alterations were
associated with a significant downregulation of Grin2bTSS+378kb
and Grin2bTSS+471kb (Figures 3E, S2C, and S2D). Therefore,
spatial genome architectures are dynamically regulated by
synaptic activity, by a mechanism that involves increased occu-
pancy of H3K9 methyltransferase at proximal Grin2b repressor
elements, and decreased access of facilitative chromatin from
distal long-range loops (Grin2bTSS+378kb and Grin2bTSS+471kb) to
the TSS and surrounding 50 regulatory sequences.
The long-range loop, GRIN2BTSS+449kb (Grin2bTSS+471kb in the
mouse), is dynamically regulated in the context of differentiation
(Figure 1C) and synaptic activity (Figure 3E), and facilitates
expression by ‘‘carrying’’ AP-1 and NRF-1 transcription factors
bound to intergenic DNA 30 to the gene, into physical proximity
with the TSS promoter-proximal sequences positioned at the
50 end of GRIN2B/Grin2b (Figure 2F). To further test whether
the long-range loop,Grin2bTSS+471kb, is involved in the regulation
of gene expression, we engineered two transcription activator-
like element (TALE) DNA-binding proteins (Boch et al., 2009;
Moscou and Bogdanove, 2009), fused to the VP64 transcrip-
tional activator domain which is comprised of four tandem
copies of the Herpes Simplex virus protein VP16 (Beerli et al.,
1998). Each TALE was designed against 20 bp of intergenic
sequence positioned 30 to Grin2b, in the distal arm of the loop
Grin2bTSS+471kb and within a 500 bp segment showing up to
90%conservation to the human homolog,GRIN2BTSS+449kb (Fig-
ure S1F). The TALE number 1, for target sequence TCAA-
TAAACGTTAACTACAC, did not affect neuronal viability (in
contrast to TALE number 2, which was designed for TAAGA-
CAAACGTCACAGATG). For TALE number 1, with the exception
of a 19 bp run on chromosome 15, no match was found in the
mm9 reference genome. Importantly, there were no additional
binding sites within 800 kb of sequence surrounding the Grin2b
TSS, even with a very low filter threshold of up to three mis-
matches. The TALE-transfected cortical neurons showed
3 days after transfection a significant, 20% increase in Grin2b
RNA. These changes were highly specific, because a related
NR2 subunit, Grin2a, and the repressive regulator Setdb1, did
not show significant changes in expression in transfected neu-
rons. Furthermore, mouse neural crest-derived Neuro2a (N2a)
and neuroblastoma x glioma hybrid NG108 cells did not show
detectable Grin2b expression in untransfected or TALE-trans-
fected cultures (Figure 3F). ChIP-PCR with a VP16 antibody to
measure TALE-VP64 occupancy confirmed sequence-specific
binding at the target in the distal arm of Grin2bTSS+471kb in trans-1002 Neuron 84, 997–1008, December 3, 2014 ª2014 Elsevier Inc.fected neurons, but not in NG108 or N2a cells (Figure 3F). This
lack of TALE binding at the target sequence in the two cell lines
cannot be explained by incomplete transfection, because
expression of the GFP tag was readily detectable in all three
cell types (Figure 3F). However, chromatin surrounding the
TALE target site showed high levels of the ‘‘open’’ chromatin
mark H3K27ac in neurons, while levels were much lower for
the corresponding sequences in NG108 and N2a cells (Fig-
ure S2E), suggesting that Grin2b chromatin was less accessible
in the cell lines. We conclude that active Grin2b expression is
sensitive to designer transcription factors binding 471 kb down-
stream from the TSS.
Having shown that higher-order chromatin is a key control
point for transcriptional regulation of GRIN2B/Grin2b in brain,
we next asked whether these mechanisms could play a potential
role in cognition and disease. We interrogated the Psychiatric
Genome Consortium 2 (PGC2) data set, with 35,476 schizo-
phrenia (SCZ) and 46,839 control subjects the largest available
genome-wide association study to date (Schizophrenia Working
Group of the Psychiatric Genomics Consortium, 2014). Within a
10 Mb portion of chromosome 12p encompassing GRIN2B, a
single SNP, rs117578877, passed the threshold of p < 106,
with p = 6.6 3 107 and estimated Odds ratio (OR) of 1.15 for
the minor (T) allele (Figure 4A). While rs 117578877 did not reach
nominal genome-wide significance (p < 5 3 108), we note the
stepwise decrease of its p value with successively larger sam-
ples as part of earlier versions of the PGC2 analysis (Schizo-
phrenia Psychiatric GWAS Consortium, 2011; Ripke et al.,
2013). Given the low minor allele frequency (cases, 5.18%; con-
trols, 4.62%), future studies in larger cohorts are expected to
reach a more definite conclusion on rs117578877 as risk poly-
morphism. Of note, rs117578877 is positioned in the center
of the distal arm of GRIN2BTSS+449kb (Figure 4A). Therefore,
noncontiguous DNA elements bypassing 0.5 Mb on the linear
genome could contribute to genetic risk for SCZ by interacting
with the GRIN2B TSS. We hypothesized that rs117578877 risk
allele carriers could show alterations in GRIN2B RNA levels in
the context of psychosis and disease. To this end, we screened
227 postmortem brains by PCR-based genotyping and identified
five SCZ cases and five controls carrying the minor allele which
confers risk. We measured GRIN2B RNA in the PFC of risk (T)
allele carriers, and in 12 SCZ and 12 controls, all C/C homozy-
gotes, for comparison. T-allele carriers with SCZ showed signif-
icantly lower GRIN2B RNA levels in comparison to controls
matched by genotype. In contrast, cases biallelic for the pro-
tective (C) allele showed GRIN2B levels similar to controls, and
furthermore, rs117578877 did not affect GRIN2B RNA levels
within controls (Figure 4B). These findings, while very prelimi-
nary, due to the small sample size of the minor allele cohort,
suggest that a risk polymorphism in the distal loop arm of
GRIN2BTSS+449kb confers decreased GRIN2B expression in the
context of SCZ. Because the majority of our disease cases
were exposed to antipsychotic medication, we assessed medi-
cation effects in a cohort of mice treated for 3 weeks with daily
i.p. injections with the conventional antipsychotic and dopamine
D2-like receptor antagonist haloperidol (0.5 mg/kg) or the
atypical antipsychotic clozapine (5 mg/kg). Consistent with an
earlier report (Fatemi et al., 2012), our antipsychotic-exposed
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Figure 4. Intergenic Sequences Affect Cognition and GRIN2B Expression
(A) Regional association plot for 100 kb surroundingGRIN2B 30 end, fromPGC2 data set (SchizophreniaWorking Group of the Psychiatric Genomics Consortium,
2014). SNP rs117578877 is within (red box number 2) distal arm of GRIN2BTSS+449kb.
(B)GRIN2BRNA in PFC from n = 12 SCZ and n = 12 control subjects biallelic for major (C) allele, and n = 5 SCZ and n = 5 control minor (T)-allele carriers. *p < 0.05
(two-tailed t test).
(C) (Left) Spatial workingmemory strategy and (right)N-back continuous performance task scores in n = 31C/T heterozygotes compared to n = 794C/C subjects.
Sole T/T subject marked by arrow (mean ± SEM, *p < 0.05, **p < 0.005, ***p < 00005 (Mann-Whitney).
(D) (Top) 248 bp from distal arm of GRIN2BTSS+449kb with a total of 15 (N)GG PAM leader sequences for CRISPR/CAS editing. (Middle, from left to right)
Transfected HEK293(FT) cells, showing high transfection efficiency (>95%) by GFP reporter and 180 kDa Cas9 protein immunoblot. Size bar, 100 micron.
Representative 5%acrylamide gels showing predicted (Table S3) banding patterns of SURVEYOR nuclease cleavage products in Cas9 nuclease-treated cultures
exposed to 13/15 sgRNAs (one sgRNA/transfection) and Cas9 nickase-treated cultures exposed to combined sgRNAs 2+7 and sgRNA 2/nuclease-treated cells.
(Bottom) DNA sequence and PAM positions (sgRNA 2 and 7, black triangles mark bp position predicted to be the primary target in nickase assays), and
electropherograms from (top to bottom) DNA clones of wild-type, sgRNA2/nuclease-exposed cells, and sgRNA2+7/nickase-exposed cells, confirming small 2 bp
(GT) deletion 50 to PAM in sgRNA2/nuclease-exposed and much larger deletions and mutations in sgRNA2+7/nickase-exposed cells. Red triangles mark site of
mutations. Bar graph (n = 3/group, mean ± SEM) showing lower GRIN2B RNA expression after sgRNA2+7/nickase, compared to mock transfected (CRISPR/
Cas9 transfected without sgRNA) as control. See also Tables S1–S4 and Figure S3.
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GRIN2B Higher-Order Chromatin and Cognitionmice showed a significant prefrontal upregulation of catechol-O-
methyltransferase (Comt) transcript. In contrast, differences in
Grin2b expression and long-range chromosomal loopings be-
tween treatment and control groups were minimal (Figures S3A
and S3B). We conclude that antipsychotic medication likely
does not affect Grin2b/GRIN2B expression in cortex.
To further test whether rs117578877 could impact cognition,
we genotyped 826 young healthy males from the Greek Learningon Genetics of Schizophrenia Spectrum (LOGOS) cohort who
previously underwent neuropsychological testing across six
cognitive domains and personality traits (Roussos et al.,
2011a, 2011b). No genotype-based difference in demographic
characteristics was found, and allele distribution was consistent
with Hardy-Weinberg expectations (p = 0.21) (Table S1). How-
ever, the T-allele carriers exhibit worse strategy (p = 0.003) on
the spatial working memory task and made more errors on theNeuron 84, 997–1008, December 3, 2014 ª2014 Elsevier Inc. 1003
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Figure 5. Spatial Working Memory Showing Significant Increase in
Repetitive Errors
Spatial working memory showing significant increase in repetitive errors,
measured as repeat entries in eight-arm radial maze on third (final) day of
testing in (left to right) C57BL6/J mice treated with GRIN2B antagonist RO
25-6981 (10 mg/kg) (n = 14–18/treatment group), drug-naive CK-Setdb1
transgenic (Tg) mice compared to wild-type (Wt) littermate control (n = 12–17/
genotype) and CK-Cre, Mll12lox/2lox (M) mice (n = 12–16/genotype). Data are
shown as mean ± SEM. *p < 0.05. See also Figure S4.
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GRIN2B Higher-Order Chromatin and CognitionN-back task (3-back: p = 6.53 105), which remained significant
after Bonferroni corrections (Figure 4C). T-allele carriers had
increased schizotypy and self-transcendence (p < 0.05) (Table
S2), two personality traits frequently associated with schizo-
phrenia spectrum disorders (Ohi et al., 2012; Vollema et al.,
2002). Furthermore, the sole biallelic T/T subject was worst
among all 826 individuals tested in each of the above tests and
questionnaires (Figure 4C).
These findings suggest that rs117578877, positioned in the
distal arm of the GRIN2BTSS+449Kb loop, is associated with liabil-
ity for cognitive performance and psychosis. Next, we quantified
the binding of nuclear proteins extracted from human PFC to
sequences encompassing rs117578877. Gel shift assays with
extracts from different PFC specimens consistently showed
stronger binding for the major (C) allele compared to the risk
(T) allele (Figures S3C and S3D). Motif loss for CCAAT/
Enhancer-Binding Protein (CEBPB), a transcriptional regulator
robustly expressed in adult PFC, could contribute to decreased
nucleoprotein affinity for the T-allele (Figures S3C and S3D).
However, regulatory sites often are comprised of multiple
enhancer and transcription factor occupancies sequentially
arranged within short genomic distance (Dickel et al., 2013; Fac-
tor et al., 2014; Smith and Shilatifard, 2014). Therefore, targeted
mutations in proximity to the rs117578877 polymorphism also
could affect GRIN2B expression. To explore this, we harnessed
clustered regularly interspaced short palindromic repeats
(CRISPR)/RNA-guided Cas9 nuclease (Ran et al., 2013) and
transfected (human) GRIN2B-expressing HEK293FT cells
altogether with 15 short-guide (sg)-RNAs directed toward NGG
motifs and Cas9-PAM recognition elements in 250 base pairs
surrounding rs117578877 (Figure 4D; Table S3). Genome editing
activity at theGRIN2B locus was confirmed for 13/15 sgRNAs by
DNA heteroduplex-sensitive SURVEYOR nuclease assays and
sequencing, typically revealing single or two base-pair insertions1004 Neuron 84, 997–1008, December 3, 2014 ª2014 Elsevier Inc.and deletions 50 to the NGG motif (Figure 4D). We then cotrans-
fected sgRNAs 2 and 7 together with a Cas9 nickase mutant,
which induces multi-base-pair genome modifications by homol-
ogy-directed repair, and minimizes or eliminates off-target ef-
fects compared to nuclease-based genome editing approaches
(Ran et al., 2013; Shen et al., 2014). Indeed, sequencing of nick-
ase-treated cultures revealed larger, up to 45 bp, deletions of
sequence positioned between the PAMs of the two sgRNAs.
This was associated with a significant, 20%–25% decrease
in GRIN2B RNA levels (Figure 4D). Therefore, GRIN2B expres-
sion is sensitive to DNA structural variants positioned 449 kb
distal to the TSS.
Our human studies support the idea that polymorphisms and
mutations in loop-bound DNA affect working memory and
GRIN2B expression. Therefore, in our final set of experiments,
we explored, in mice, the link betweenGrin2b higher-order chro-
matin andworkingmemory. Alterations inGrin2b expression and
activity impact cognition in mice (Tang et al., 1999). Unsurpris-
ingly, we found in multiple cohorts of wild-type C57Bl6 animals
exposed to the GRIN2B antagonist Ro25-6981 (10 mg/kg i.p.)
impairments in spatial working memory as measured by repeat
entries (‘‘errors’’) in the eight-arm radial maze (Figures 5 and
S4A). A similar working memory defect was found in drug-naive
CK-Setdb1 transgenic mice, compared to littermate controls
(Figure 5). This was associated with weakening of long-range
loops Grin2bTSS+378kb and Grin2bTSS+471kb and decreased
Grin2b RNA and protein in PFC (Figures 3C and 3D). These
changes in higher-order chromatin are due to SETDB1-mediated
repression and heterochromatization around the TSS and prox-
imal introns, thereby antagonizing facilitatory effects on neuronal
gene expression mediated by long-range loops Grin2bTSS+378kb
and Grin2bTSS+471kb (Figures 2C, 2F, 3C, and S2A). We next
asked whether similar behavioral phenotypes could be elicited
by epigenetic dysregulation other than SETDB1 overexpression.
To this end, we discovered that Kmt2a/Mll1 conditional mutant
mice subject to CK-Cre-mediated deletion in postnatal forebrain
neurons showed a significant decrease in prefrontal Grin2b
RNA and protein expression (Figure S4B), in conjunction with
impaired working memory in the radial arm maze test (Figure 5).
Of note, Kmt2a/Mll1 (Lysine methyltransferase 2a/Mixed lineage
leukemia 1) regulates histone H3K4 methylation which—in sharp
contrast to SETDB1-regulated H3K9 methylation and repres-
sion—shows broad correlations with open chromatin and active
gene expression on a genome-wide scale (Guenther et al., 2005;
Gupta et al., 2010; Peter and Akbarian, 2011). Using ChIP-PCR,
we measured in PFC of adult CK-Cre,Kmt2a2lox/2lox mice the
levels of mono-, di-, and trimethylated H3K4 (H3K4me1/2/3)
(Figures S4C and S4D). Of note, neuronal loss of Kmt2a in PFC
neurons was associated with a specific, 40% decrease of
H3K4me1 at Grin2bTSS+378kb. These H3K4me1 changes were
significant, in contrast to the moderate decrease in TSS-bound
H3K4me3 and H3K4me2. Using 3C ChIP-loop assays, we
were able to confirm H3K4me1 enrichment in higher-order
chromatin associated withGrin2bTSS+378kb in the cerebral cortex
(Figure S4C). Finally, we examined mice deficient for the
neuron-specific Baf53b chromatin remodeling subunit. Com-
plete loss ofBaf53b is associated with perinatal lethality. Hetero-
zygous Baf53b+/ animals are viable but show severe neuronal
Neuron
GRIN2B Higher-Order Chromatin and Cognitiondysfunction and defective learning and cognition (Vogel-Ciernia
et al., 2013). Interestingly, adult Baf53b+/ cortex maintained
normal levels of Grin2b expression and chromosomal loopings
(Figure S4E). These findings would suggest that the alterations
in Grin2b expression and higher-order chromatin, as observed
in CK-Setdb1 and CK-Cre/Kmt2a2lox/2lox mutant mice, are spe-
cific and not reflective of a generalized response to neuronal
disease.
DISCUSSION
Spatial Genome Architectures at GRIN2B Play a Role
in Transcriptional Regulation
We mapped physical interactions of noncontiguous DNA
across 800 kb at the GRIN2B (Grin2b) locus on chr 12
(mouse: chr 6). Two long-range loopings, GRIN2BTSS+348kb ‘and
GRIN2BTSS+449kb, orGrin2bTSS+378kb andGrin2bTSS+471kb as their
murine homologs, were epigenetically decorated with sharp
peaks for the open chromatin marks, H3K27ac, and H3K4me1,
which in this combination often define active enhancers
(Maston et al., 2012). The GRIN2BTSS+449kb loop carried a cargo
of proteins previously reported to promote Grin2b expression,
including the Ca2+/cAMP-response element binding protein
(CREB)-regulated NRF-1 (Herzig et al., 2000) and early-response
AP-1 (Dhar and Wong-Riley, 2009; Priya et al., 2013; Qiang and
Ticku, 2005) transcription factors. Consistent with the definition
of a classical promoter-enhancer loop—defined by the mobiliza-
tion of conserved DNA elements into close proximity of a TSS
to facilitate transcription (Ong and Corces, 2011)—the higher-
order chromatin structures described here were specific for
cells expressing GRIN2B, with dynamic coregulation of loopings
and expression in the context of differentiation and increased
synaptic activity. It remains to be determined whether these
changes in chromosomal conformations occur independently
or in context with other activity-regulated changes in neuronal
nuclei, including plasticity in nuclear geometry (Wittmann et al.,
2009), mobilization of transcribed genes away from the nuclear
lamina and other repressive environments (Walczak et al.,
2013), and repositioning into subnuclear territories enriched
with the transcriptional initiation complex (Crepaldi et al., 2013)
and highly transcribed genes such as the (nuclear-encoded)
cytochrome c oxidase subunits (Dhar et al., 2009). Furthermore,
according to genome-wide estimates, five independent en-
hancers could regulate the same TSS (Andersson et al., 2014),
and therefore is it possible that GRIN2B expression is governed
by the two long-range loops described here and additional
regulatory sequences positioned 50 or 30 from the TSS.
Chromosomal Conformations Affect Cognition
Folding the genome into three-dimensional chromatin structures
is of pivotal importance for neuronal function, withmutations and
structural variants in far more than 50 genes, each encoding a
different chromatin regulator, now linked to neurodevelopmental
syndromes (Ronan et al., 2013) and adult onset hereditary neuro-
degenerative disease (Jakovcevski and Akbarian, 2012; Klein
et al., 2011; Winkelmann et al., 2012). Neurological disease
associated with disordered chromatin includes mutations in
CTCF, encoding a scaffolding protein implicated in the structuralorganization of promoter-enhancer loopings (Gregor et al., 2013;
Merkenschlager and Odom, 2013). Brain development and
cognition are also affected by deleterious mutations in histone
methyltransferase encoding genes, including KMT2A/MLL1
(Jones et al., 2012) andKMT1E/SETDB1 (Cukier et al., 2012). Ac-
cording to our 3C ChIP-loop results, there is robust enrichment
for CTCF protein in GRIN2BTSS+449kb loop chromatin. Further-
more, we observed that working memory in mice is dependent
on normal levels of Grin2b expression and affected by changes
in higher-order chromatin caused by decreased H3K4monome-
thylation at distal loop elements after neuronal ablation of
Kmt2a methyltransferase, and by excessive, Kmt1e/Setdb1
transgene-mediated H3K9 trimethylation at repressor se-
quences 30–40 kb downstream from the TSS. These intronic
sequences were enriched for heterochromatin-associated
protein 1 (HP-1a) in the context of increased occupancy of
KMT1E/SETDB1 histone H3K9 methyltransferase promoting
local chromatin compaction (Mund et al., 2012; Verschure
et al., 2005). Our findings point to highly complex regulation
of the spatial genome architectures at the GRIN2B/Grin2b
locus, defined by dynamic competition of multiple loopings
competing for access to gene-proximal regulatory sequences,
in order to facilitate or repress expression (Figure 2F). Therefore,
disruption in three-dimensional genome organization, including
but not limited to the GRIN2B locus, could severely impact
neuronal functions after mutations in CTCF, KMT2A/MLL1,
KMT1E/SETDB1, and probably additional chromatin regulators
associated with cognitive and psychiatric disease (Takata
et al., 2014).
Changes in Grin2b expression and activity profoundly affect
memory and cognition (Tang et al., 1999; von Engelhardt et al.,
2008), while mutations and microdeletions encompassing the
GRIN2B locus are associated with schizophrenia and autism
(Endele et al., 2010; Jia et al., 2012; Talkowski et al., 2012).
The present study extends these findings and describes how
higher-order chromatin encompassing the GRIN2B locus adds
further liability to cognitive impairments. This includes an inter-
genic SNP, rs117578877, which in the 826 subjects of the
LOGOS cohort was linked to working memory performance
and psychosis-related personality traits. In addition, GRIN2B
RNA levels were decreased in PFC of risk allele carriers diag-
nosed with SCZ, and multi-base-pair deletion in close proximity
to this polymorphism negatively affected GRIN2B expression
in HEK cells. Interestingly, an earlier GWAS study measuring
workingmemory in 750 subjects reported rs2160519, positioned
within 3 kb from the distal arm of GRIN2BTSS+348kb, as third-top-
scoring SNP genome-wide (Need et al., 2009). Additional SNPs,
positioned at the TSS and around repressive SETDB1 target
sequences, conferred significant effects on memory function in
a third study with 330 subjects (de Quervain and Papassotiro-
poulos, 2006) (Figure S3E). These studies, taken together with
the findings presented here, strongly suggest that multiple
loop-bound sequence variants affect GRIN2B expression and
cognition.
It is remarkable that, according to our results, NMDA recep-
tor gene expression could be modulated by a TALE-based
designer transcription factor in mouse cortical neurons—and
by CRISPR/Cas-induced multi-base-pair excisions in HEKNeuron 84, 997–1008, December 3, 2014 ª2014 Elsevier Inc. 1005
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GRIN2B Higher-Order Chromatin and Cognitioncells—that both were targeted to intergenic DNA separated by
0.5 Mb from the GRIN2B/Grin2b TSS. While the resulting
changes in expression, particularly in case of our TALE-VP64
transcription factor, were modest, our results mark a significant
extension from the previously reported epigenomic editing of
Drosophila enhancers located within 10 kb from their target
genes (Crocker and Stern, 2013). We predict that the molecular
toolbox for future treatments of cognitive and psychiatric
disease will include targeted editing of long-range enhancer
elements regulating gene expression critical for neuronal plas-
ticity and behavior.EXPERIMENTAL PROCEDURES
Chromosome Conformation Capture
Cerebral cortex (300 mg/human postmortem specimen or unilateral mouse
cortical hemisphere) or cultured cells (up to 107 cells) were crosslinked for
15min in PBS-buffered 1.5% formaldehyde, then digested with Hind III restric-
tion enzyme (NEB) at 37C overnight, washed, and treated with T4 DNA ligase
at 16C for 4 hr followed by by DNA extraction and purification using standard
protocols. Chromosome conformation capture (3C) primers were 30–32 bp in
length and positioned within 200 bp of HindIII cut sites. Sequence-verified
PCR products were measured semiquantitatively with UVP Bioimaging sys-
tem/Labworks 4.5 software.
TALE-Based Designer Transcription Factor
Two transcription activator-like element DNA-binding proteins (TALE), fused to
four tandem copies of the herpes simplex viral protein 16, amino acids 437–
447, DALDDFDLDML connected with glycine-serine linkers, were targeted
to intergenic sequences in the mouse genome, 471 kb downstream of the
Grin2b TSS using the TALE tool box kit (Addgene). Sequence confirmed
clones were transfected into mouse primary cortical neurons (E17) at DIV 4
and RNA extracted 72 hr posttransfection.
Genome Editing
To induce mutations in DNA surrounding rs117578877, 15 sgRNAs were iden-
tified by searching for the G(N)20 GG motifs that conform with the nucleotide
requirements for U6 Pol III transcription and the spCas9 PAM recognition
element (PAM) (Ran et al., 2013), and corresponding oligonucleotides were
cloned into pX330 vector (Addgene), sequence confirmed, and transfected
into HEK293FT cells. At 72 hr posttransfection, genomic DNA was extracted
to verify CRISPR-Cas9-mediated editing by using the mismatch-sensitive
SURVEYOR nuclease assay (Ran et al., 2013). A subset of sgRNAs with
confirmed editing activity in the SURVEYOR assay were subsequently used
in double nicking assays using Addgene’s pX335 vector.
A detailed description of all experimental procedures, the neuropsycholog-
ical test cohort (LOGOS), postmortem brain samples, mutant mice, and cell
lines is provided in the Supplemental Information.SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, five tables, and Supplemental
Experimental Procedures and can be found with this article at http://dx.doi.
org/10.1016/j.neuron.2014.10.032.
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